Literature DB >> 6232086

Predominance of two newly described capsular polysaccharide types among clinical isolates of Staphylococcus aureus.

R D Arbeit, W W Karakawa, W F Vann, J B Robbins.   

Abstract

A capsular polysaccharide typing schema for Staphylococcus aureus, based upon the preparation of rabbit typing sera with eight prototype strains, has been reported ( Karakawa and Vann , 1982). These antisera were used to classify the capsular polysaccharides of 246 S. aureus isolates from patients in a survey of hospitals in several countries and 49 consecutive blood isolates obtained over a 17-month period in a clinical study at the Boston Veterans' Administration Medical Center. Two capsular types, 5 and 8, accounted for about 70% of these isolates; most of the remaining strains could not be typed with the available antisera. The clinical study of bacteremia identified capsular types 5 and 8 among both community-acquired and nosocomial isolates and showed that strains bearing these two types caused the patterns of disease reported for staphylococcal bacteremia. There was an association between the phage type and the capsular type of these bacteremic strains. The capsular types of the "classic" encapsulated strains of S. aureus, M (type 1) and Smith (type 2), were not observed among blood isolates in this study. The observation that most clinical isolates of S. aureus belong to two recently defined capsular types provides a new focus for investigations into the virulence of this common nosocomial pathogen and suggests the potential for protective acquired immunity against staphylococcal bacteremia.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6232086     DOI: 10.1016/0732-8893(84)90002-6

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN: 0732-8893            Impact factor:   2.803


  70 in total

1.  Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.

Authors:  S Ouyang; S Sau; C Y Lee
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  MsaB activates capsule production at the transcription level in Staphylococcus aureus.

Authors:  Justin L Batte; Dhritiman Samanta; Mohamed O Elasri
Journal:  Microbiology       Date:  2016-01-18       Impact factor: 2.777

3.  Identification of the capsular polysaccharides in Staphylococcus aureus clinical isolates by PCR and agglutination tests.

Authors:  Isabelle Verdier; Geraldine Durand; Michele Bes; Kimberly L Taylor; Gerard Lina; François Vandenesch; Ali I Fattom; Jerome Etienne
Journal:  J Clin Microbiol       Date:  2007-01-03       Impact factor: 5.948

4.  Correlation between esterase electrophoretic types and capsular polysaccharide types 5 and 8 among methicillin-susceptible and methicillin-resistant strains of Staphylococcus aureus.

Authors:  C Branger; P Goullet; A Boutonnier; J M Fournier
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

5.  Rapid and reliable identification of Staphylococcus aureus capsular serotypes by means of artificial neural network-assisted Fourier transform infrared spectroscopy.

Authors:  Tom Grunert; Mareike Wenning; María Sol Barbagelata; Martina Fricker; Daniel O Sordelli; Fernanda R Buzzola; Monika Ehling-Schulz
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

6.  False susceptibility of enterococci to aminoglycosides with blood-enriched Mueller-Hinton agar for disk susceptibility testing.

Authors:  R D Jenkins; S L Stevens; J M Craythorn; T W Thomas; M E Guinan; J M Matsen
Journal:  J Clin Microbiol       Date:  1985-09       Impact factor: 5.948

7.  Vaccine assembly from surface proteins of Staphylococcus aureus.

Authors:  Yukiko K Stranger-Jones; Taeok Bae; Olaf Schneewind
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-30       Impact factor: 11.205

8.  Virulence of Staphylococcus aureus mutants altered in type 5 capsule production.

Authors:  A Albus; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1991-03       Impact factor: 3.441

9.  Phagocytic killing of encapsulated and microencapsulated Staphylococcus aureus by human polymorphonuclear leukocytes.

Authors:  S Xu; R D Arbeit; J C Lee
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

Review 10.  Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Authors:  Matthew T Novak; James D Bryers; William M Reichert
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.